Given the immunoregulatory roles of CKI on HCC and its broad-spectrum anticancer activity, we attempted to explore whether the combination of CKI and chemotherapy could enhance the anti-tumor immunity in TNBC. Here, CHKA is linked to hepatocellular carcinoma.